Unchained Labs Acquires NanoView Biosciences

Unchained Labs Acquires Blacktrace Group from Maven

July 24, 2023

Medical Devices

Unchained Labs, backed by Carlyle-affiliated investment funds and Unchained management, has acquired Blacktrace Group (Blacktrace Holdings) from investor Maven. The acquisition brings Blacktrace’s microfluidics and Particle Works LNP formulation and scale-up technologies into Unchained’s life-science tools portfolio to accelerate capabilities for lipid nanoparticle, gene therapy and vaccine research.

The Carlyle Group Acquires Unchained Labs

April 26, 2021

Medical Devices

The Carlyle Group agreed to acquire life sciences tools company Unchained Labs for $435 million from Novo Holdings A/S, Canaan Partners and TPG Biotech, in a transaction expected to close in Q2 2021. Carlyle will partner with Unchained Labs' management to accelerate organic and inorganic growth through investments in R&D, digitization and geographic expansion; Unchained is headquartered in Pleasanton, California and had ~170 employees and ~$75M revenue projected for 2021.

Bionano Genomics Acquires BioDiscovery

October 12, 2021

Software

Bionano Genomics agreed to acquire BioDiscovery, a provider of NxClinical genomics analysis software, in a deal worth up to $100 million in cash and equity. The acquisition will integrate BioDiscovery's platform-agnostic analysis and reporting tools with Bionano's optical genome mapping technology to accelerate variant analysis and broaden Bionano's market reach; BioDiscovery founder Soheil Shams will join Bionano as Chief Informatics Officer.

Bruker Corporation Acquires NanoString Technologies Business

May 6, 2024

Medical Devices

Bruker Corporation has acquired substantially all assets of NanoString Technologies, Inc. through a court-supervised Chapter 11 asset sale for approximately $392.6 million in cash plus assumption of certain liabilities. The deal, announced April 2024 and closed in late April/early May 2024, brings NanoString's spatial biology and gene-expression product lines into Bruker to preserve customer access, product development, and jobs while expanding Bruker's life‑science instrumentation capabilities.

NanoTemper Technologies Acquires Envue Technologies

November 6, 2025

Biotechnology

NanoTemper Technologies has acquired Envue Technologies, a Swedish spinout that developed Nanofluidic Scattering Microscopy (NSM), to expand its single-molecule and label-free analysis capabilities. The deal integrates Envue's NSM technology into NanoTemper's biophysical analysis portfolio and coincides with NanoTemper's launch of the Dianthus α application to enhance early-stage drug discovery workflows.

VION Biosciences Acquires Echelon Biosciences

August 22, 2024

Biotechnology

VION Biosciences, the life-science platform backed by Iron Path Capital, has acquired Salt Lake City-based Echelon Biosciences, a specialist supplier of lipid-based excipients and lipid nanoparticles. The add-on strengthens VION's capabilities in lipid synthesis and lipid nanoparticle technology to support mRNA and gene-therapy development and advances the platform toward drug manufacturing while keeping Echelon’s leadership and operations intact.